- Country: Russia
- Summary: Delivery of Drugs in 2025 (Lot 111: Mnn Docatoxel_Idarubicin_Asparaginaza_ Brassomib)
- RUT Ref No: 115495610
- Deadline: 05 Mar 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: RUB 2431991.2
- Notice Type: Tender
- Document Ref. No.: 0348200027025000101
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Delivery of drugs in 2025 (Lot 111: MNN Docatoxel_idarubicin_asparaginaza_ Brassomib)
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINDelivery of Drugs in 2025 (Lot 111: Mnn Docatoxel_Idarubicin_Asparaginaza_ Brassomib) - Russian Tender
The STATE BUDGETARY INSTITUTION OF HEALTH OF THE MOSCOW REGION "MOSCOW REGIONAL RESEARCH CLINICAL INSTITUTE NAMED AFTER M.F. VLADIMIRSKY, a Government sector organization in Russia, has announced a new tender for Delivery of Drugs in 2025 (Lot 111: Mnn Docatoxel_Idarubicin_Asparaginaza_ Brassomib). This tender is published on RussianTenders under RUT Ref No: 115495610 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-03-05.
The estimated tender value is RUB 2431991.2, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
